Prostate Cancer urine test more accurate

The PSA test is the standard measure of prostate cancer, but is fraught with problems and not always accurate. But German researchers have found a urine test that tracks RNA molecules linked to cancer may offer a better, more accurate way to detect the disease.
This study, presented at the European Association of Urology Congress (EAU16) in Munich this week, was conducted by the University of Leipzig and the Fraunhofer Institute for Cell Therapy and Immunology. The German researchers have identified a series of non-coding RNA molecules that could potentially be combined into a single urine test to detect prostate cancer. Such a test holds promise for offering greater sensitivity and specificity than the current biomarker tests and thus make population screening much more viable."Given that our initial results show a high specificity for prostate cancer in urine tests, the prospects are good that we will be able to translate this into a better test for prostate cancer," Wirth said.